Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of $6.58 million. The enterprise value is $4.44 million.
Important Dates
The last earnings date was Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.31 million shares outstanding. The number of shares has increased by 46.18% in one year.
| Current Share Class | 8.97M |
| Shares Outstanding | 17.31M |
| Shares Change (YoY) | +46.18% |
| Shares Change (QoQ) | +10.03% |
| Owned by Insiders (%) | 51.52% |
| Owned by Institutions (%) | 4.08% |
| Float | 6.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | 3.21 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.17.
| Current Ratio | 4.63 |
| Quick Ratio | 4.16 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -220.07 |
Financial Efficiency
Return on equity (ROE) is -404.51% and return on invested capital (ROIC) is -103.49%.
| Return on Equity (ROE) | -404.51% |
| Return on Assets (ROA) | -75.54% |
| Return on Capital (ROIC) | -103.49% |
| Revenue Per Employee | $47,787 |
| Profits Per Employee | -$26,235 |
| Employee Count | 162 |
| Asset Turnover | 2.20 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.77% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -65.77% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 43.52 |
| Average Volume (20 Days) | 257,501 |
Short Selling Information
The latest short interest is 501,975, so 2.90% of the outstanding shares have been sold short.
| Short Interest | 501,975 |
| Short Previous Month | 174,155 |
| Short % of Shares Out | 2.90% |
| Short % of Float | 7.73% |
| Short Ratio (days to cover) | 1.90 |
Income Statement
In the last 12 months, Syra Health had revenue of $7.74 million and -$4.25 million in losses. Loss per share was -$0.64.
| Revenue | 7.74M |
| Gross Profit | 1.78M |
| Operating Income | -4.25M |
| Pretax Income | -4.19M |
| Net Income | -4.25M |
| EBITDA | -4.18M |
| EBIT | -4.25M |
| Loss Per Share | -$0.64 |
Full Income StatementBalance Sheet
The company has $2.70 million in cash and $565,712 in debt, giving a net cash position of $2.13 million or $0.12 per share.
| Cash & Cash Equivalents | 2.70M |
| Total Debt | 565,712 |
| Net Cash | 2.13M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 3.33M |
| Book Value Per Share | 0.19 |
| Working Capital | 3.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.47 million and capital expenditures -$11,111, giving a free cash flow of -$4.49 million.
| Operating Cash Flow | -4.47M |
| Capital Expenditures | -11,111 |
| Free Cash Flow | -4.49M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
Gross margin is 22.94%, with operating and profit margins of -54.89% and -54.90%.
| Gross Margin | 22.94% |
| Operating Margin | -54.89% |
| Pretax Margin | -54.90% |
| Profit Margin | -54.90% |
| EBITDA Margin | -54.02% |
| EBIT Margin | -54.89% |
| FCF Margin | n/a |